Literature DB >> 24732358

Positive association of long telomeres with the invasive capacity of hepatocellular carcinoma cells.

Eunkyong Ko1, Guhung Jung2.   

Abstract

Invasion, the representative feature of malignant tumors, leads to an increase in mortality. The malignant liver tumor - hepatocellular carcinoma (HCC) - has an enhanced invasive capacity that results in increased patient mortality. Moreover, this enhanced invasive capacity is due to the up-regulation of invasion promoters such as zinc finger protein SNAI1 (Snail) and matrix metalloproteinases (MMPs), and the down-regulation of invasion suppressor molecules such as E-cadherin. Telomerase reverse transcriptase (TERT), which encodes the catalytic subunit of telomerase, is highly expressed in a variety of invasive cancers, including HCC. Telomerase activation induces telomere elongation, thereby leading to cell immortalization during malignant tumor progression. However, the relationship between telomere length and invasion is yet to be experimentally corroborated. In this paper, we revealed that invasive HCC cells passing through the Matrigel display significantly longer telomeres than non-invasive HCC cells. Moreover, we established a method that can distinguish and sort cells containing long telomeres and short telomeres. Using this system, we observed that the HCC cells containing long telomeres had a high-level expression of invasion-promoting genes and a low-level expression of invasion-suppressing E-cadherin. Furthermore, HCC cells containing long telomeres exhibited a higher invasive capacity than HCC cells containing short telomeres. Taken together, our findings suggest that long telomeres are positively associated with the invasive capacity of HCC cells and may be a potent target for malignant liver cancer treatment.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); Invasion; Telomerase reverse transcriptase (TERT); Telomere

Mesh:

Year:  2014        PMID: 24732358     DOI: 10.1016/j.bbrc.2014.04.022

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States.

Authors:  Baiyu Yang; Fatma M Shebl; Lawrence R Sternberg; Andrew C Warner; David E Kleiner; Daniel C Edelman; Allison Gomez; Casey L Dagnall; Belynda D Hicks; Sean F Altekruse; Brenda Y Hernandez; Charles F Lynch; Paul S Meltzer; Katherine A McGlynn
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

2.  Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial.

Authors:  Andrea Casadei Gardini; Emanuela Scarpi; Elena Orlandi; Davide Tassinari; Silvana Leo; Ilaria Bernardini; Fabio Gelsomino; Stefano Tamberi; Silvia Ruscelli; Roberto Vespignani; Sonia Ronconi; Giovanni Luca Frassineti; Dino Amadori; Alessandro Passardi
Journal:  Onco Targets Ther       Date:  2018-08-29       Impact factor: 4.147

3.  Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study.

Authors:  Andrea Casadei-Gardini; Emanuela Scarpi; Paola Ulivi; Maria Angela Palladino; Caterina Accettura; Ilaria Bernardini; Andrea Spallanzani; Fabio Gelsomino; Jody Corbelli; Giorgia Marisi; Silvia Ruscelli; Martina Valgiusti; Giovanni Luca Frassineti; Alessandro Passardi
Journal:  Cancer Manag Res       Date:  2019-05-10       Impact factor: 3.989

4.  Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.

Authors:  Junfei Jin; Pengpeng Zhu; Yan Liao; Jun Li; Weijia Liao; Songqing He
Journal:  Oncotarget       Date:  2015-08-07

5.  The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.

Authors:  Eunkyong Ko; Hyun-Wook Seo; Eun Sun Jung; Baek-hui Kim; Guhung Jung
Journal:  Oncotarget       Date:  2016-01-05

6.  Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma.

Authors:  Qiang Ma; Jiajing Cai; Yan Cai; Yuan Xu; Fan Chang; Lei Xu; Guoyuan Zhang; Xiaolan Guo
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

7.  Association of ACYP2 and MPHOSPH6 genetic polymorphisms with the risk of hepatocellular carcinoma in chronic hepatitis B virus carriers.

Authors:  Yingai Zhang; Shunlan Wang; Xiaohong Wen; Shufang Zhang; Yijun Yang
Journal:  Oncotarget       Date:  2017-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.